A detailed history of Kelly Financial Services LLC transactions in Uni Qure N.V. stock. As of the latest transaction made, Kelly Financial Services LLC holds 224 shares of QURE stock, worth $1,258. This represents 0.0% of its overall portfolio holdings.

Number of Shares
224
Previous 224 -0.0%
Holding current value
$1,258
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 17, 2024

BUY
$11.12 - $22.2 $1,890 - $3,774
170 Added 314.81%
224 $2.57 Million
Q4 2022

Jul 17, 2024

BUY
$18.12 - $27.32 $978 - $1,475
54 New
54 $1.22 Million

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $263M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Kelly Financial Services LLC Portfolio

Follow Kelly Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Financial Services LLC with notifications on news.